BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $13
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Jeffrey Silber maintains an Outperform rating on TrueBlue (NYSE:TBI) but lowers the price target from $15 to $13.

May 08, 2024 | 11:53 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
TrueBlue's Outperform rating is maintained by BMO Capital, though its price target is reduced from $15 to $13.
The maintenance of an Outperform rating suggests a positive outlook on TrueBlue by BMO Capital, indicating confidence in the company's fundamentals or growth prospects. However, the reduction in the price target could reflect adjustments in valuation models, possibly due to revised earnings expectations or market conditions. This mixed signal might lead to a neutral short-term impact on the stock price, as the market digests the positive endorsement against the backdrop of a lower valuation target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100